Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects
Clinical trial NCT02121509 · COMPLETED
Trial details
- NCT number
- NCT02121509
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2014-07-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.